Barry Kappel, PhD, MBA
President and CEO
Sapience Therapeutics, Inc.
Scientist to Biotechnology Entrepreneur
No single experience will prepare an individual to start a biotechnology company from the ground up; one must amass a skill set that includes but is not limited to science, drug development, corporate strategy and governance, finance and human resources, while also possessing an extraordinary sense of self-belief. Dr. Barry Kappel spent the past 20 years building the skills to successfully launch his own company, Sapience Therapeutics, and will share the story of his transition from science to start-up.
Prior to founding Sapience, Dr. Kappel was a senior executive of ContraFect Corporation, a company which he played an integral part in founding in 2009. As the Senior Vice President of Business Development, he was involved in all aspects of the company, including financing activities, licensing of the company's key technologies, establishing scientific collaborations with academic and corporate partners, presenting to regulatory authorities and developing a corporate strategy. Prior to ContraFect, Dr. Kappel was a Senior Consultant at Easton Associates, LLC, a boutique life science consulting firm located in Manhattan. Easton Associates has since been acquired by Navigant Consulting.
Dr. Kappel holds B.A. in Chemistry from Emory University, a Ph.D. in Immunology and Pharmacology from the Weill Cornell Graduate School of Medical Sciences and Memorial Sloan-Kettering Cancer Center, and an MBA from the S.C. Johnson Graduate School of Management at Cornell University. Dr. Kappel was also chosen as a Howard Hughes Pre-Doctoral Fellow and has been an author on 17 publications in peer-reviewed scientific journals.